Third-Party BK Virus-Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation.
Amanda OlsonRuitao LinDavid MarinHind RafeiMustafa H BdaiwiPeter F ThallRafet BasarAla AbudayyehPinaki BanerjeeFleur M AungIndresh KaurGlorette AbuegSheetal RaoRoy F ChemalyVictor MulanovichGheath Al-AtrashAmin M AlousiBorje S AnderssonPaolo AnderliniQaiser BashirKarla M CastroMay DaherIsabel M GalvanChitra HosingJin S ImRoy B JonesPartow KebriaeiIssa F KhouriRohtesh S MehtaJeffrey MolldremYago L NietoBetül OranSairah A AhmedMuzaffar QazilbashGabriela RondonNeeraj SainiBryan SpencerSamer SrourDominique WashingtonMelissa BarnettRichard E ChamplinElizabeth J ShpallKatayoun RezvaniPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Off-the-shelf BKV-CTLs are a safe and effective therapy for the management of patients with BKV-HC after AHSCT.
Keyphrases